Qiagen
Stock
Stock
ISIN: NL0015002CX3
Ticker: QGEN
NL0015002CX3
QGEN
Price
Price
CHART BY
Frequently asked questions
What is Qiagen's market capitalization?
The market capitalization of Qiagen is $9.25B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Qiagen's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Qiagen is 102.54. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Qiagen?
Qiagen's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.417. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Qiagen's stock?
Currently, 24 analysts cover Qiagen's stock, with a consensus target price of $49.43. Analyst ratings provide insights into the stock's expected performance.
What is Qiagen's revenue over the trailing twelve months?
Over the trailing twelve months, Qiagen reported a revenue of $2.00B.
Is Qiagen paying dividends?
Yes, Qiagen is paying dividends. The next payment is scheduled for 10.07.2025, with an expected amount of .
What is the EBITDA for Qiagen?
Qiagen's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $714.72M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Qiagen?
Qiagen has a free cash flow of $505.68M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Qiagen have, and what sector and industry does it belong to?
Qiagen employs approximately 5,765 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Qiagen's shares?
The free float of Qiagen is 214.42M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $9.25B
- EPS (TTM)
- $0.417
- Free Float
- 214.42M
- P/E ratio (TTM)
- 102.54
- Revenue (TTM)
- $2.00B
- EBITDA (TTM)
- $714.72M
- Free Cashflow (TTM)
- $505.68M
Pricing
- 1D span
- $42.64$43.07
- 52W span
- $37.65$49.29
Analyst Ratings
The price target is $49.43 and the stock is covered by 24 analysts.
Buy
13
Hold
11
Sell
0
Information
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
- Employees
- 5,765
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- NL0015002CX3
- Primary Ticker
- QGEN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet